טוען...
Cystic fibrosis transmembrane conductance regulator modulators: precision medicine in cystic fibrosis
PURPOSE OF REVIEW: The aim of this study was to describe the newest development in cystic fibrosis (CF) care, CF transmembrane conductance regulator (CFTR) modulator therapies. RECENT FINDINGS: Phase II results showing CFTR modulator triple therapies are more effective than current CFTR modulators....
שמור ב:
| הוצא לאור ב: | Curr Opin Pediatr |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6398332/ https://ncbi.nlm.nih.gov/pubmed/29538046 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MOP.0000000000000627 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|